Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.3 to v3.6.4 in the history, signaling a new build or update of the page. This reflects deployment/maintenance activity rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-22T16:40:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3 on the study entry, representing a minor metadata update to the ClinicalTrials.gov record. It does not alter study details, eligibility, locations, or results.
    Difference
    0.0%
    Check dated 2026-07-01T09:31:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The substudy page now shows that recruitment is closed for new participants and adds user-facing sections to help visitors read the study record and find information on joining; a minor heading reform for the Intervention/Treatment section and a page revision note (v3.6.0) are also present.
    Difference
    0.3%
    Check dated 2026-06-16T00:26:24.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5 and the previous v3.5.4 tag was removed, indicating a new release of the page content. This appears to be an administrative/versioning update rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-06-09T01:17:07.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4. This signals a small update to the page metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-05-18T13:53:35.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Changed the Age eligibility in the study to '18 Years and older' from the previous '18 Years to 120 Years', removing the upper age limit and expanding which adults may enroll in the trial.
    Difference
    0.2%
    Check dated 2026-05-11T12:18:14.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.